Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - alectinib hydrochloride 161.33mg equivalent to alectinib 150mg - capsule - 150 mg - active: alectinib hydrochloride 161.33mg equivalent to alectinib 150mg excipient: black ink (alecensa) carmellose calcium carnauba wax carrageenan hyprolose hypromellose lactose monohydrate magnesium stearate maize starch potassium chloride sodium laurilsulfate titanium dioxide - alecensa is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive, locally advanced or metastatic non-small cell lung cancer (nsclc).

Australia - inglés - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - etoposide phosphate, quantity: 113.6 mg - injection, powder for - excipient ingredients: sodium citrate dihydrate; dextran 40 - for use in the treatment of: small cell carcinoma of the lung; acute monocytic and myelomonocytic leukaemia; hodgkin's disease; non- hodgkin's lymphoma and testicular tumours.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

australian health foods pty ltd - propolis, quantity: 200 mg/ml (equivalent: propolis, qty 200 mg/ml) - liquid, multipurpose - excipient ingredients: ethanol; purified water - for the temporary relief of cough and symptoms of colds when applied to the skin for relief of minor skin irritations.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

bayer limited - praziquantel - oral gel - 90 mg/g - praziquantel - equine - food - endoparasiticide

Reino Unido - inglés - VMD (Veterinary Medicines Directorate)

bayer plc - praziquantel - oral gel - anthelmintic - horses

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - meropenem trihydrate 1.14155 g equivalent to of meroopenem 1 g;   - powder for injection - 1 g - active: meropenem trihydrate 1.14155 g equivalent to of meroopenem 1 g   excipient: nitrogen sodium carbonate - indicated for treatment, in adults and children, of lower respiratory tract infections.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - meropenem trihydrate 570.78mg equivalent to meropenem 500 mg;   - powder for injection - 500 mg - active: meropenem trihydrate 570.78mg equivalent to meropenem 500 mg   excipient: nitrogen sodium carbonate - indicated for treatment, in adults and children, of lower respiratory tract infections.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 1148 mg (equivalent: amoxicillin, qty 1000 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; sodium starch glycollate type a; hypromellose; titanium dioxide; purified talc - amoxycillin sandoz is indicated in the treatment of acute exacerbation of chronic bronchitis. notes: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. amoxycillin sandoz 1000mg tablets have not been shown to be bioequivalent to the 500mg and 250mg capsule formulations given in equivalent doses. therefore, amoxycillin sandoz 1000mg tablets and other forms of amoxycillin are not considered interchangeable. infections caused by pathogens with established penicllin g susceptibility should preferentially be treated with penicillin g.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 15mg equivalent to 13.5 mg oxycodone base - modified release tablet - 15 mg - active: oxycodone hydrochloride 15mg equivalent to 13.5 mg oxycodone base excipient: lactose monohydrate magnesium stearate methacrylic acid copolymer opadry grey 05b97512 povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 30mg equivalent to 27 mg oxycodone base - modified release tablet - 30 mg - active: oxycodone hydrochloride 30mg equivalent to 27 mg oxycodone base excipient: lactose monohydrate magnesium stearate methacrylic acid copolymer opadry brown ys-1-16518-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia